Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research ...

Elo Mutual Pension Insurance trimmed its stake in Vertex Pharmaceuticals by 4% in Q4, now holding $9.49 million in shares. Several other institutional investors also made notable adjustments, with ...

The PGIM Jennison Focused Growth Fund rose 5.7%, slightly underperforming the Russell 1000 Growth Index. Click here to read ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

This is the unique (3,7)-cage, meaning a graph such that each vertex has 3 neighbors and the shortest cycle has length 7.

Homeworld, the slow-burning deep space strategy game, is one of my favorites of all time. Coldly evocative of the artwork of ...

After witnessing an upswing in funding for two consecutive weeks, the Indian startup ecosystem hit a rough patch from March ...

Moves by the Dow Jones Industrial Average and other major indexes improved ever so slightly Friday afternoon. The Nasdaq ...

Poco F7 Ultra may support with 120W wired, 50W wireless charging Both handsets could carry 50-megapixel OIS-supported main camera units The Poco F7 Pro, F7 Ultra phones may get a 6.67-inch AMOLED ...

Google’s Chirp 3 AI model supports text-to-speech Chirp 3 offers 248 distinct voices with eight speaker options Google says AI-generated voices are useful for podcast narration ...

The unexpected popularity of Manus, a so-called computer-using AI that takes over a person’s web browser to execute tasks like travel booking and stock analysis, has put the Chinese startup behind it ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...